MOH Maintained by UBS -- Price Target Raised to $225

gurufocus.com · 2026-10-23

Molina Healthcare (MOH) Analyst Rating Update - September 26, 2023 On September 26, 2023, UBS maintained a Neutral rating on Molina Healthcare (MOH). The pri

TickrTrends take: UBS raised its price target for MOH to $225, which represents an analyst endorsement of the company's fundamentals despite TickrTrends' current assessment that the stock is overvalued. For valuation-focused investors, this divergence between the analyst's higher price target and the overvalued designation suggests monitoring whether MOH can demonstrate earnings growth or operational improvements sufficient to justify its current valuation multiples in the Healthcare sector. The maintenance rating paired with the raised target indicates analyst confidence in the company's trajectory, making it a stock to track for potential shifts in valuation metrics.

Read the full story at gurufocus.com →